Why the study?
Do pharmacologic and device-based therapies prevent sudden cardiac death in patients with chronic kidney disease?
Population
Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD)
Design
Review
Authors
Loading...
Alerts clinicians to SCD risk in CKD without changing ICD practice; leaves open optimal preventive strategies for prospective trials.
Do pharmacologic and device-based therapies prevent sudden cardiac death in patients with chronic kidney disease?
This review highlights the independent association between CKD and sudden cardiac death, emphasizing the need for targeted risk stratification and prospective trials to evaluate the efficacy and safety of preventive therapies in this high-risk population.
Whitman et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: